The importance of in situ dosimetry during photodynamic therapy of Barrett's esophagus.

[1]  G. Bourg-Heckly,et al.  Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagus. , 2004, Gastrointestinal endoscopy.

[2]  Stephen G Bown,et al.  Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus. , 2005, Gastrointestinal endoscopy.

[3]  Masoud Panjehpour,et al.  Centering balloon to improve esophageal photodynamic therapy , 1992, Lasers in surgery and medicine.

[4]  Rick E. Sneed,et al.  Comparative study between pulsed and continuous wave lasers for Photofrin® photodynamic therapy , 1993, Lasers in surgery and medicine.

[5]  T. Stephenson,et al.  Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial , 2000, Gut.

[6]  Steven L. Jacques,et al.  Laser Tissue Interaction XIII: Photochemical, Photothermal, and Photomechanical , 1999 .

[7]  J. Shah,et al.  Management of Barrett's oesophagus , 1996, The Lancet.

[8]  P. Siersema.  Photodynamic therapy for Barrett's esophagus: not yet ready for the premier league of endoscopic interventions. , 2005, Gastrointestinal endoscopy.

[9]  Henricus J C M Sterenborg,et al.  In situ light dosimetry during photodynamic therapy of Barrett's esophagus with 5‐aminolevulinic acid , 2002, Lasers in surgery and medicine.

[10]  N. J. Brown,et al.  Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett’s esophagus , 2004, Surgical Endoscopy And Other Interventional Techniques.

[11]  Henricus J C M Sterenborg,et al.  Dose and Timing of the First Light Fraction in Two-fold Illumination Schemes for Topical ALA-mediated Photodynamic Therapy of Hairless Mouse Skin¶ , 2003, Photochemistry and photobiology.

[12]  H. S. de Bruijn,et al.  Improvement of systemic 5-aminolevulinic acid-based photodynamic therapy in vivo using light fractionation with a 75-minute interval. , 1999, Cancer research.

[13]  B. Wilson,et al.  Instrumentation and light dosimetry for intra-operative photodynamic therapy (PDT) of malignant brain tumours. , 1986, Physics in medicine and biology.

[14]  Bergein F Overholt,et al.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.

[15]  H. Wolfsen.  Carpe luz--seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodium. , 2005, Gastrointestinal endoscopy.

[16]  H.J.C.M. Sterenborg,et al.  Skin optics , 1989, IEEE Transactions on Biomedical Engineering.

[17]  Stanley B. Brown,et al.  Fluorescence Photobleaching of ALA‐induced Protoporphyrin IX during Photodynamic Therapy of Normal Hairless Mouse Skin: The Effect of Light Dose and Irradiance and the Resulting Biological Effect , 1998, Photochemistry and photobiology.

[18]  M Panjehpour,et al.  Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus. , 1993, Gastrointestinal endoscopy.

[19]  Henricus J C M Sterenborg,et al.  Protoporphyrin IX Fluorescence Photobleaching and the Response of Rat Barrett's Esophagus Following 5-aminolevulinic Acid Photodynamic Therapy , 2006, Photochemistry and photobiology.

[20]  C J Stoddard,et al.  Endoscopic ablation of Barrett's oesophagus: a randomized‐controlled trial of photodynamic therapy vs. argon plasma coagulation , 2004, Alimentary pharmacology & therapeutics.

[21]  Mary N. Phan,et al.  Optimization of light dosimetry for photodynamic therapy of Barrett's esophagus: efficacy vs. incidence of stricture after treatment , 2005 .

[22]  M. V. van Gemert,et al.  Light dosimetry: status and prospects. , 1987, Journal of photochemistry and photobiology. B, Biology.

[23]  H. Barr,et al.  Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX , 1996, The Lancet.

[24]  E. Steyerberg,et al.  5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett’s oesophagus: a randomised trial , 2004, Gut.

[25]  H. S. de Bruijn,et al.  Monitoring In Situ Dosimetry and Protoporphyrin IX Fluorescence Photobleaching in the Normal Rat Esophagus During 5-Aminolevulinic Acid Photodynamic Therapy¶ , 2003 .